Cbd Life Sciences Inc (CBDL)
CBD Life Sciences Inc. is a common stock listing on OTC Markets. The company develops and markets cannabidiol-based organic products, with offerings that include hemp drops, massage oils, recovery pain relief creams, supplements aimed at anxiety and sleep support, edibles, coffee, wine, skincare products, tablets, and pet products. The company was formerly known as Optium Cyber Systems, Inc., and adopted its current name in January 2019. CBD Life Sciences Inc. is based in Scottsdale, Arizona.
Stock Summary Fair Value Profitability & Growth Quality & Risk Events & Dividends Market Outlook FAQ
Jump directly to the stock analysis sections supported by the latest available data.
Data update note:
Fair value and stock analysis metrics are updated after regular market sessions when new data becomes available.
| Ticker | Fair Value | Analyst Price Target | Analyst Target Upside/Downside | Overall Financial Health | Dividend Yield | Next Earnings Date | Price-to-Book Ratio | Price-to-Sales Ratio | Market Cap | Enterprise Value | Total Debt / Total Capital | Altman Z-Score | Free Cash Flow / Net Income |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
OTC-CBDL
|
Not available
|
Not available
|
Not available
|
Fair
|
0.0%
|
December 4, 2026
|
1.7x
|
12.1x
|
1.186 M
|
820.883 K
|
0.0%
|
-12.2
|
284.4%
|
